Latest Breaking News On - Biocryst pharmaceuticals inc nasdaq - Page 1 : comparemela.com

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Oct. 04, 2023 BioCryst Pharmaceuticals, Inc. today announced that the compensation committee of BioCryst’s board of directors granted 23 newly-hired employees.

United statesJohn bluthGlobenewswire incBiocryst pharmaceuticals incBiocryst pharmaceuticals inc nasdaqBiocryst pharmaceuticalsCryst pharmaceuticalsNasdaq listing ruleInducement equity incentive planMedia contact

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., June 06, 2023 BioCryst Pharmaceuticals, Inc. today announced that the compensation committee of BioCryst’s board of directors granted 11 newly-hired. | June 6, 2023

United statesJohn bluthBiocryst pharmaceuticalsBiocryst pharmaceuticals incBiocryst pharmaceuticals inc nasdaqGlobenewswire incCryst pharmaceuticalsNasdaq listing ruleInducement equity incentive planNc stock exchangePress release1 bcrx us09058v1035

BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 European Academy of Allergy and Clinical Immunology Congress

BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 European Academy of Allergy and Clinical Immunology Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJohn bluthBiocryst pharmaceuticals inc nasdaqExchange commissionBiocryst pharmaceuticalsEuropean academy of allergyBiocryst pharmaceuticals incWall streetCryst pharmaceuticals incClinical immunologyThematic poster sessionImportant safetyLooking statementsthisAnnual reportQuarterly reportsCurrent reports

BioCryst to Present New ORLADEYO (berotralstat) Data at 2023 European Academy of Allergy and Clinical Immunology Congress

31.05.2023 - RESEARCH TRIANGLE PARK, N.C., May 31, 2023 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) today announced that the company will present two abstracts featuring data on oral, once-daily ORLADEYO (berotralstat) for the prophylactic . Seite 1

European academy of allergyClinical immunology congressBiocryst pharmaceuticals inc nasdaqPresent newCryst pharmaceuticals incClinical immunologyThematic poster sessionImportant safetyBiocryst pharmaceuticals